NG
NVO

NWK Group’s Novo Nordisk NVO Stock Holding History

NWK Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56,838
Closed -$6.77M – 76
2024
Q3 		$6.77M Sell
56,838
-645
-1% -$86K 2.75% 16
2024
Q2 		$8.21M Buy
57,483
+97
+0.2% +$12.9K 3.45% 13
2024
Q1 		$7.37M Buy
57,386
+1,232
+2% +$147K 3.45% 13
2023
Q4 		$5.81M Buy
56,154
+910
+2% +$90K 2.99% 16
2023
Q3 		$5.02M Buy
55,244
+1,162
+2% +$102K 3.08% 17
2023
Q2 		$4.38M Sell
54,082
-198
-0.4% -$16.2K 2.56% 18
2023
Q1 		$4.32M Buy
+54,280
New +$3.85M 2.81% 15

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

NWK Group's NVO Position: Q4 2024 in Review

NWK Group sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 56,838 shares — an estimated $6.77M sold.

NWK Group first reported a position in NVO in Q1 2023 and held it in 7 quarters. The position peaked at $8.21M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • NWK Group reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • NWK Group sold 56,838 Novo Nordisk shares in Q4 2024, an estimated $6.77M.
  • NWK Group first reported a position in Novo Nordisk in Q1 2023 and held it in 7 quarters.
  • NWK Group's Novo Nordisk position peaked at $8.21M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on NWK Group's 13F filing for Q4 2024, filed 13 Feb 2025.